Form D · Biotechnology

Endosee Corp

Los Altos, CA · CIK 0001534100

Offering snapshot reported Jun 2, 2014 · SEC filing

Reported sold
$1.81M
Offering amount: $2.6M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 16, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$903K$1.81MJan 31, 2014: $1,005,083.00Jan 31, 2014Jun 2, 2014: $1,805,083.00Jun 2, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,005,083 → $1,805,083
  • Reported investors7 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 2, 2014Amendment$1,805,083$800,000vs Jan 31, 201410SEC filing
Jan 31, 2014Initial$1,005,083No comparison7SEC filing
Feb 6, 2013Initial$1,679,982No comparison8SEC filing
Nov 10, 2011Initial$887,672No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-211047

Source: Form D, filed Jun 2, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul D. Indman Director, Executive
Xiaolong (Bruce) Ou Yang Director, Executive
Kevin Rooney Executive
Shih Ping (Bob) Wang Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4546 El Camino Real, Suite 215
Los Altos, CA, 94022